-
It is India’s first pneumococcal conjugate vaccine (PCV) developed recently by Serum Institute of India in collaboration with partners like the Bill and Melinda Gates Foundation.
-
Pneumosil targets the pneumococcal bacterium, which causes pneumonia and other serious life-threatening diseases such as meningitis and sepsis.
-
Vaccine will ensure that children are protected better against pneumococcal disease.
-
Pneumococcal disease is a significant contributor under-five mortality rate worldwide and cause nearly four lakh deaths in children each year worldwide.